Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2010
Near IR heptamethine cyanine dye-mediated cancer imagingXiaojian Yang, Chunmeng Shi, Rong Tong, et al.Journal of Assisted Reproduction and Genetics|September 10, 2024
Technically feasible solutions to challenges in preimplantation genetic testing for thalassemia: experiences of multiple centers between 2019 and 2022Zi Ren, Peng Huang, Yong Wang, et al.Plos One|November 24, 2011
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signalingHui-Wen Lue, Xiaojian Yang, Ruoxiang Wang, et al.Journal of Global Health|September 20, 2024
Prevalence and disparities in sexual and reproductive health of women of reproductive age (20-49 years) in China: A national cross-sectional studyTian Tian, Rui Yang, Yu Fu, et al.BMJ Open|July 27, 2022
Embryo selection through non-invasive preimplantation genetic testing with cell-free DNA in spent culture media: a protocol for a multicentre, double-blind, randomised controlled trialJin Huang, Li Rong, Lin Zeng, et al.Cancer Gene Therapy|February 11, 2022
Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imagingHua Yang, Shanshan Tan, Jingjuan Qiao, et al.Bulletin of the World Health Organization|April 2, 2024
Fertility history and intentions of married women, ChinaQin Li, Rui Yang, Zehong Zhou, et al.American Journal of Obstetrics and Gynecology|August 7, 2022
Age-specific random day serum antimüllerian hormone reference values for women of reproductive age in the general population: a large Chinese nationwide population-based surveyYongxiu Hao, Rui Yang, Jia Li, et al.The Lancet Regional Health. Western Pacific|June 7, 2022
Changes in the prevalence of polycystic ovary syndrome in China over the past decadeRui Yang, Qin Li, Zehong Zhou, et al.Reproductive Biology and Endocrinology : RB&E|October 4, 2022
Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injectionRui Yang, Yunshan Zhang, Xiaoyan Liang, et al.Pageof 15